BetterLife Pharma BETRF
OTC BETRF
$0.24 -0.02 (-9.23%)
As of: Aug 21, 2026 · 2:48 PM EDT

BetterLife Pharma (BETRF) Amortization of Deferred Charges (2019 - 2020)

BetterLife Pharma (BETRF) posted quarterly Amortization of Deferred Charges of $19995.1 for Q4 2020, down 74.69% year-over-year from $79006.4 in Q4 2019, and down 65.53% quarter-over-quarter from $58001.4 in Q3 2020.

BetterLife Pharma (BETRF) Amortization of Deferred Charges (2019 - 2020) Analysis & Trends

BetterLife Pharma's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $19995.1 for Q4 2020.

  • In Q4 2020, Amortization of Deferred Charges fell 74.69% year-over-year to $19995.1; the TTM figure through Jan 2021 stood at $135716.7 (down 57.4% YoY), while the FY2021 annual figure was $138437.3, down 56.55% from the prior year.
  • Amortization of Deferred Charges for Q4 2020 stood at $19995.1, down from $58001.4 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $81992.9 in Q1 2020, with the low at $19995.1 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BetterLife Pharma 36.45 Mn 36.42 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2020 19,995.08
Oct 31, 2020 19,995.08
Jul 31, 2020 58,001.40
Jul 31, 2020 58,001.40
Apr 30, 2020 57,720.21
Apr 30, 2020 57,720.21
Jan 31, 2020 81,992.86
Jan 31, 2020 81,992.86
Oct 31, 2019 79,006.39
Oct 31, 2019 79,006.39
Jul 31, 2019 79,848.82
Jul 31, 2019 79,848.82
Apr 30, 2019 77,761.23
Apr 30, 2019 77,761.23